×
About 270 results

ALLMedicine™ Frontotemporal Degeneration Center

Research & Reviews  97 results

Lexical and Acoustic Speech Features Relating to Alzheimer Disease Pathology.
https://doi.org/10.1212/WNL.0000000000200581
Neurology Cho S, Quilico Cousins KA et. al.

Apr 30th, 2022 - We compared digital speech and language features of patients with amnestic Alzheimer's disease (aAD) or logopenic variant primary progressive aphasia (lvPPA) in a biologically confirmed cohort and related these features to neuropsychiatric test sc...

Support Via Technology: Living and Learning With Advancing FTD
https://clinicaltrials.gov/ct2/show/NCT05338710

Apr 21st, 2022 - Much effort over the last several decades has been devoted to developing and implementing psychoeducational interventions for family caregiving partners for those with Alzheimer's and related dementias (ADRD). However, few interventions address th...

Divergent Histopathological Networks of Frontotemporal Degeneration Proteinopathy Subyt...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087810
The Journal of Neuroscience : the Official Journal of The... Chen M, Ohm DT et. al.

Mar 24th, 2022 - Network analyses inform complex systems such as human brain connectivity, but this approach is seldom applied to gold-standard histopathology. Here, we use two complimentary computational approaches to model microscopic progression of the main sub...

Insights on FTD: An externally led patient-focused drug development meeting.
https://doi.org/10.1002/alz.057701
Alzheimer's & Dementia : the Journal of the Alzheimer's A... Niehoff D, Dodge SG et. al.

Feb 4th, 2022 - Understanding the lived experience of those affected by a disorder should be central to the development and evaluation of therapeutics. Disease-specific Externally Led Patient-Focused Drug Development (EL-PFDD) meetings were established by the FDA...

FTD Disorders Registry (FTDDR) disease impact survey: Understanding the lived experienc...
https://doi.org/10.1002/alz.056556
Alzheimer's & Dementia : the Journal of the Alzheimer's A... Wheaton DK, Harlass S et. al.

Feb 4th, 2022 - FTD is a group of rare brain diseases that cause myriad progressive changes to behavior, personality, language, and movement with onset typically before age 60. There are currently no treatments or cure. The FTDDR is a regulatory-compliant, web-ba...

see more →

Clinicaltrials.gov  4 results

Support Via Technology: Living and Learning With Advancing FTD
https://clinicaltrials.gov/ct2/show/NCT05338710

Apr 21st, 2022 - Much effort over the last several decades has been devoted to developing and implementing psychoeducational interventions for family caregiving partners for those with Alzheimer's and related dementias (ADRD). However, few interventions address th...

UPenn Observational Research Repository on Neurodegenerative Disease
https://clinicaltrials.gov/ct2/show/NCT04715399

Jan 27th, 2022 - The Principal Investigator (PI) at the University of Pennsylvania seeks to better understand neurodegenerative diseases and is continually expanding research efforts and collaborations regarding the factors which may contribute to these illnesses....

Improving Self-Care of Behavioral Variant Frontotemporal Dementia Caregivers
https://clinicaltrials.gov/ct2/show/NCT04686266

Jan 11th, 2022 - Informal caregivers of persons with Frontotemporal degeneration (FTD) are an understudied population with unique needs. FTD is a common cause of young-onset dementia with no known cure. Behavioral variant FTD (bvFTD) is the most common of the FTD ...

DAPHNE Scale Validation in Frontotemporal Lobar Degeneration
https://clinicaltrials.gov/ct2/show/NCT02889601

Aug 21st, 2017 - Psycho-behavioral disorders assessment is crucial for the diagnosis and follow-up of patients with frontotemporal degeneration (FTD). DAPHNE scientific staff have therefore developed a quantification and follow-up scale specifically dedicated to p...

see more →

News  7 results

Antipsychotic Safe, Effective for Dementia-Related Psychosis
https://www.medscape.com/viewarticle/955276

Jul 22nd, 2021 - Continued treatment with the atypical antipsychotic pimavanserin (Nuplazid) reduces risk for recurring delusions and hallucinations related to dementia, new data reveal. Phase 3 results from the HARMONY study show patients with dementia who stayed...

Twofold Increased ALS Risk in Manual Laborers
https://www.medscape.com/viewarticle/949580

Apr 20th, 2021 - Blue-collar workers, particularly carpenters and construction workers, have a significantly increased risk for amyotrophic lateral sclerosis (ALS) compared with white-collar workers, new research shows. Investigators found manual laborers had a tw...

FTD Takes a Greater Financial Toll Than Alzheimer's
https://www.medscape.com/viewarticle/886562

Oct 4th, 2017 - The financial costs associated with frontotemporal degeneration (FTD), the most common dementia in patients under age 60 years, are nearly twice as high as those associated with Alzheimer's disease (AD), new research shows. Results from the web-ba...

New and Noteworthy Information—October 2017
https://www.mdedge.com/node/148016/path_term/51946

Sep 26th, 2017 - Is Vitamin D Deficiency a Risk Factor for MS? Vitamin D deficiency is a risk factor for multiple sclerosis (MS), according to a study published online ahead of print September 13 in Neurology. Researchers conducted a prospective nested case-contro.

Association for Frontotemporal Degeneration Conference Set for May 5
https://www.mdedge.com/clinicianreviews/article/130679/infectious-diseases/association-frontotemporal-degeneration

Feb 3rd, 2017 - The 2017 Association for Frontotemporal Degeneration (AFTD) Education Conference will take place on May 5 at the Sheraton Inner Harbor Hotel in Baltimore. Online registration will open January 9.

see more →